메뉴 건너뛰기




Volumn 12, Issue 5, 2011, Pages 521-525

Efficacy and tolerability of pregabalin as preventive treatment for migraine: A 3-month follow-up study

Author keywords

Disability; Migraine; Pregabalin; Prophylaxis therapy

Indexed keywords

AMITRIPTYLINE; CINNARIZINE; FLUNARIZINE; GABAPENTIN; PREGABALIN; PROPRANOLOL; TOPIRAMATE; VALPROIC ACID;

EID: 80054035326     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-011-0338-0     Document Type: Article
Times cited : (29)

References (18)
  • 1
    • 0037177103 scopus 로고    scopus 로고
    • Migraine in the United States: Epidemiology and patterns of health care use
    • RB Lipton AI Scher K Kolodner, et al. 2002 Migraine in the United States. Epidemiology and patterns of health care use Neurology 58 6 885 894 11914403 1:STN:280:DC%2BD387ot1Wqtw%3D%3D (Pubitemid 34242063)
    • (2002) Neurology , vol.58 , Issue.6 , pp. 885-894
    • Lipton, R.B.1    Scher, A.I.2    Kolodner, K.3    Liberman, J.4    Steiner, T.J.5    Stewart, W.F.6
  • 2
    • 0141894069 scopus 로고    scopus 로고
    • Global burden of migraine in the year 2000
    • Accessed5Nov2009
    • Leonardi M, Mathers C (2000) Global burden of migraine in the year 2000. Summary of methods and data sources. http://www.who.int/entity/healthinfo/ statistics/bod-migraine.pdf. Accessed 5 Nov 2009
    • (2000) Summary of Methods and Data Sources
    • Leonardi, M.1    Mathers, C.2
  • 3
    • 0028453699 scopus 로고
    • Migraine prevalence. A review of population-based studies
    • 8008222 1:STN:280:DyaK2c3nslersw%3D%3D
    • WF Stewart A Shechter BK Rasmussen 1994 Migraine prevalence. A review of population-based studies Neurology 44 6 Suppl 4 S17 S23 8008222 1:STN:280:DyaK2c3nslersw%3D%3D
    • (1994) Neurology , vol.44 , Issue.6 SUPPL. 4
    • Stewart, W.F.1    Shechter, A.2    Rasmussen, B.K.3
  • 4
    • 53049095681 scopus 로고    scopus 로고
    • Clinical course in migraine: Conceptualizing migraine transformation
    • 18779513 10.1212/01.wnl.0000325565.63526.d2
    • ME Bigal RB Lipton 2008 Clinical course in migraine: conceptualizing migraine transformation Neurology 71 11 848 855 18779513 10.1212/01.wnl. 0000325565.63526.d2
    • (2008) Neurology , vol.71 , Issue.11 , pp. 848-855
    • Bigal, M.E.1    Lipton, R.B.2
  • 5
    • 33646805362 scopus 로고    scopus 로고
    • Emerging drugs for migraine prophylaxis and treatment
    • ME Bigal AV Krymchantowski 2006 Emerging drugs for migraine prophylaxis and treatment Med Gen Med 8 2 31
    • (2006) Med Gen Med , vol.8 , Issue.2 , pp. 31
    • Bigal, M.E.1    Krymchantowski, A.V.2
  • 6
    • 34247137215 scopus 로고    scopus 로고
    • Current trends in migraine prophylaxis
    • DOI 10.1111/j.1526-4610.2007.00677.x
    • NM Ramadan 2007 Current trends in migraine prophylaxis Headache 47 Suppl 1 S52 S57 17425710 10.1111/j.1526-4610.2007.00677.x (Pubitemid 46587635)
    • (2007) Headache , vol.47 , Issue.SUPPL. 1
    • Ramadan, N.M.1
  • 7
    • 0242509095 scopus 로고    scopus 로고
    • Newer Antiepileptic Drugs: Possible Uses in the Treatment of Neuropathic Pain and Migraine
    • DOI 10.1016/S0149-2918(03)80314-4
    • M Pappagallo 2003 Newer antiepileptic drugs: possible uses in the treatment of neuropathic pain and migraine Clin Ther 25 10 2506 2538 14667954 10.1016/S0149-2918(03)80314-4 1:CAS:528:DC%2BD3sXpvVGksLs%3D (Pubitemid 37373928)
    • (2003) Clinical Therapeutics , vol.25 , Issue.10 , pp. 2506-2538
    • Pappagallo, M.1
  • 8
    • 33646231746 scopus 로고    scopus 로고
    • Prophylactic pharmacotherapy for migraine headaches
    • 16628529 10.1055/s-2006-939919
    • TM Buchanan NM Ramadan 2006 Prophylactic pharmacotherapy for migraine headaches Semin Neurol 26 2 188 198 16628529 10.1055/s-2006-939919
    • (2006) Semin Neurol , vol.26 , Issue.2 , pp. 188-198
    • Buchanan, T.M.1    Ramadan, N.M.2
  • 9
    • 33645321130 scopus 로고    scopus 로고
    • Migraine headache prophylaxis: Current options and advances on the horizon
    • 16522261 10.1007/s11910-996-0030-y 1:CAS:528:DC%2BD28Xjt12ntL0%3D
    • NM Ramadan 2006 Migraine headache prophylaxis: current options and advances on the horizon Curr Neurol Neurosci Rep 6 2 95 99 16522261 10.1007/s11910-996-0030-y 1:CAS:528:DC%2BD28Xjt12ntL0%3D
    • (2006) Curr Neurol Neurosci Rep , vol.6 , Issue.2 , pp. 95-99
    • Ramadan, N.M.1
  • 10
    • 77649258248 scopus 로고    scopus 로고
    • Role of antiepileptic drugs as preventive agents for migraine
    • 20030417 10.2165/11310970-000000000-00000 1:CAS:528:DC%2BC3cXivVamsL4%3D
    • M Vikelis AM Rapoport 2010 Role of antiepileptic drugs as preventive agents for migraine CNS Drugs 24 1 21 33 20030417 10.2165/11310970-000000000- 00000 1:CAS:528:DC%2BC3cXivVamsL4%3D
    • (2010) CNS Drugs , vol.24 , Issue.1 , pp. 21-33
    • Vikelis, M.1    Rapoport, A.M.2
  • 12
    • 76749095867 scopus 로고    scopus 로고
    • Pregabalin in the treatment of chronic migraine: An open-label study
    • 19935409 10.1097/WNF.0b013e3181bf1dbe 1:CAS:528:DC%2BC3cXht12gtLY%3D
    • EP Calandre JM Garcia-Leiva F Rico-Villademoros JS Vilchez CM Rodriguez-Lopez 2010 Pregabalin in the treatment of chronic migraine: an open-label study Clin Neuropharmacol 33 1 35 39 19935409 10.1097/WNF. 0b013e3181bf1dbe 1:CAS:528:DC%2BC3cXht12gtLY%3D
    • (2010) Clin Neuropharmacol , vol.33 , Issue.1 , pp. 35-39
    • Calandre, E.P.1    Garcia-Leiva, J.M.2    Rico-Villademoros, F.3    Vilchez, J.S.4    Rodriguez-Lopez, C.M.5
  • 13
    • 53449093881 scopus 로고    scopus 로고
    • Remission of migraine attacks in a patient with depression who is taking pregabalin
    • 18670248 10.1097/WNF.0b013e31814a62e1
    • VG Masdrakis P Oulis NA Karakatsanis C Potagas AV Kouzoupis CR Soldatos 2008 Remission of migraine attacks in a patient with depression who is taking pregabalin Clin Neuropharmacol 31 4 238 240 18670248 10.1097/WNF. 0b013e31814a62e1
    • (2008) Clin Neuropharmacol , vol.31 , Issue.4 , pp. 238-240
    • Masdrakis, V.G.1    Oulis, P.2    Karakatsanis, N.A.3    Potagas, C.4    Kouzoupis, A.V.5    Soldatos, C.R.6
  • 14
    • 33947254401 scopus 로고    scopus 로고
    • Pregabalin: A novel γ-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders
    • DOI 10.1016/j.clinthera.2007.01.013, PII S0149291807000276
    • DM Tassone E Boyce J Guyer D Nuzum 2007 Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders Clin Ther 29 1 26 48 17379045 10.1016/j.clinthera.2007.01.013 1:CAS:528:DC%2BD2sXjsVOnsr0%3D (Pubitemid 46415802)
    • (2007) Clinical Therapeutics , vol.29 , Issue.1 , pp. 26-48
    • Tassone, D.M.1    Boyce, E.2    Guyer, J.3    Nuzum, D.4
  • 15
    • 77958133085 scopus 로고    scopus 로고
    • Pregabalin: An alpha2-delta (alpha2-delta) ligand for the management of fibromyalgia
    • 20586522
    • L Arnold P Mease S Silverman 2010 Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgia Am J Manag Care 16 5 Suppl S138 S143 20586522
    • (2010) Am J Manag Care , vol.16 , Issue.5 SUPPL.
    • Arnold, L.1    Mease, P.2    Silverman, S.3
  • 17
    • 5344249471 scopus 로고    scopus 로고
    • Pregabalin pharmacology and its relevance to clinical practice
    • E Ben-Menachem 2004 Pregabalin pharmacology and its relevance to clinical practice Epilepsia 45 Suppl 6 13 18 15315511 10.1111/j.0013-9580.2004.455003.x 1:CAS:528:DC%2BD2cXpslGisr0%3D (Pubitemid 39350325)
    • (2004) Epilepsia , vol.45 , Issue.SUPPL. 6 , pp. 13-18
    • Ben-Menachem, E.1
  • 18
    • 80054011736 scopus 로고    scopus 로고
    • Headache Classification Committee of the International Headache Society 2nd edn. Cephalalgia.
    • Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia. 24(Suppl 1):1-160
    • The International Classification of Headache Disorders , vol.24 , Issue.SUPPL. 1 , pp. 1-160


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.